Study 1
Compared efficacy of deslorelin acetate at concentrations of 0.45, 0.9, 1.35 and 1.8 mg/mL with each group compared to placebo. There were 10 mares per treatment arm.
| Treatment Group | Ovulation by 48 hours |
| Placebo | 20% |
| SucroMate™ 1.0 mL | 90% |
Conclusion
The 1.0 mL SucroMate™ dose (1.8 mg/mL deslorelin acetate) was the most effective for advancing ovulation to within 48 hours following treatment.
Study 2
A second study confirmed that 1.8 mg/mL SucroMate™ was more effective in advancing ovulation compared to a
0.9 mg/mL dose and a 1.35 mg/mL dose.
| Treatment Group | Ovulation by 48 hours |
| Placebo | 0% (0/12) |
| SucroMate™ 1.0 mL | 82% (9/11) |
Conclusion
The 1.0 mL SucroMate™ dose (1.8 mg/mL deslorelin acetate) was the most effective for advancing ovulation to within 48 hours following treatment. There was no detrimental effect on the cycle of administering SucroMate™ on 3 consecutive cycles.
Study 3: Field Based Safety and Efficacy Study
|
|
Efficacy Results
| Treatment Group | No. Cycles | No. Mares | Ovulated by 48 hours |
| Placebo | 131 | 97 | 27% |
| SucroMate™ | 142 | 94 | 77% |
Safety Results
There was no sensitivity to the touch nor increase in skin temperature observed at any injection site in either the placebo or SucroMate™ treated mares in any cycle.
Slight swelling occurred in the injection site in 3 mares in each treatment group on day 1 in Cycle 1 and 1 mare
on days 0 and 3 in Cycle 2.
Additional Studies
Efficacy of Deslorelin Acetate (SucroMate) on Induction of Ovulation in
American Quarter Horse Mares